Your session is about to expire
← Back to Search
Olaratumab for Soft Tissue Sarcoma
Study Summary
This trial is testing a new combination cancer treatment to see if it is safe for people who have previously been treated for advanced or metastatic soft tissue sarcoma.
- Soft Tissue Sarcoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What maladies is Olaratumab typically employed to address?
"Olaratumab is often utilized to treat malignant neoplasms, while it has also been known to provide relief for sufferers of unresectable melanoma, microsatellite instability high, and chemotherapy-induced disease progression."
What adverse effects have been observed in patients taking Olaratumab?
"Data regarding Olaratumab's efficacy and safety is scarce, which has led to our team at Power giving it a score of 1."
What is the current enrollment capacity of this research endeavor?
"At this moment, no further recruitment is needed for the study which was initially listed on 3rd July 2017 and lastly updated 19th July 2022. If you are looking to join other studies, there are currently 444 trials with an open enrollment policy for sarcoma and 962 clinical trial spots available for Olaratumab."
Are there any opportunities to enroll in this trial at the present time?
"According to the clinicaltrials.gov database, this trial is no longer recruiting subjects; it was last updated on July 19th 2022 after initially being posted on March 7th 2017. Nevertheless, there are currently 1,406 other studies actively looking for volunteers."
What additional investigations have been conducted using Olaratumab?
"Currently, there are 962 distinct clinical studies being conducted into Olaratumab. 123 of these trials have reached Phase 3 and 35861 medical centres globally are running the experiments. Houston, Texas is a major hub for research into this drug."
Share this study with friends
Copy Link
Messenger